Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Syquant Capital Olivier Leymarie And Henri Jeantet | 596,393 | $757 | 0.17% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 522,057 | $720,439 | 0.41% | |
| 2. | 252,930 | $350,958 | 0.02% | |
| 3. | 119,632 | $165,092 | 0% | |
| 4. | 2,590 | $3,575 | 0% | |
| 5. | 2,325 | $3,209 | 0% |